Beruflich Dokumente
Kultur Dokumente
78
78
Osteomyelitis
Kathleen Gutierrez
Osteomyelitis is inflammation of bone. Bacteria are the usual etiologic agents, but fungal osteomyelitis occurs occasionally. Osteomyelitis in children primarily has hematogenous origin, occurring
less commonly as a result of trauma, surgery, or infected contiguous soft tissue. Osteomyelitis due to vascular insufficiency is rare
in children.
Epidemiology
Approximately half of all cases of AHO occur in the first 5 years
of life.11 Boys are affected twice as frequently as girls, except in the
first year of life.11,12 One-third of patients have minor trauma to
the affected extremity before infection, but the specific importance
of this history is unclear, because virtually all young children
experience frequent mild trauma.13
The relative risk of developing osteomyelitis appears to be
higher in some populations. In one study, Polynesian and Maori
children were more likely to develop complicated osteomyelitis
with Staphylococcus aureus than other children in the same New
Zealand community.14 It is unclear whether genetic or socioeconomic or environmental factors accounted for this difference.
Microbiology
469
PART II Clinical Syndromes and Cardinal Features of Infectious Diseases: Approach to Diagnosis and Initial Management
SECTION K Bone and Joint Infections
Laboratory Diagnosis
Bacteriologic diagnosis can be confirmed in 50% to 80% of cases
of AHO; the yield is highest when multiple specimens, including
blood, bone, and joint fluid, are sampled.3,12,13,17,18,39 Cultures
obtained by imaging-guided bone biopsy are more likely to be
positive if larger volumes (>2mL) of purulent material are aspirated.43 Diagnosis of K. kingae infection is enhanced with intraoperative inoculation of culture material directly into liquid media
or onto agar plates or when polymerase chain reaction (PCR)
analysis is performed;20,21,44 cultures should be held for at least 7
to 10 days.
The erythrocyte sedimentation rate (ESR) is elevated in up to
90% of cases of osteomyelitis, and the C-reactive protein (CRP)
level in 98%.17,18,38,45 The mean ESR is 40 to 60mm/h, but levels
>100mm/h can occur. ESR generally peaks 3 to 5 days after initiation of therapy and returns to normal in approximately 3 weeks.
CRP levels peak by the second day (mean, 8.3mg/dL) and return
to normal (<2.0mg/dL) after approximately 1 week of therapy.45
Patients infected with PVL-positive versus PVL-negative S. aureus
are more likely to have positive blood cultures and higher ESR and
CRP levels at presentation.38 Higher levels of CRP at diagnosis may
predict greater risk of sequelae.46,47 The peripheral white blood cell
count can be elevated or normal; thrombocytosis can be noted,
especially if symptoms have been present for more than 1 week.
Radiologic Diagnosis
Plain Radiographs
Humerus
12%
Ulna
3%
Hands and
feet 13%
Radius
4%
Pelvis
9%
Radionuclide Scanning
Femur
27%
Tibia
22%
Fibula
5%
470
Radionuclide scans are useful in the early diagnosis of osteomyelitis, even when plain radiographs are normal. Technetiumlabeled methylene diphosphonate isotope is most frequently used
because its uptake by infected bone is enhanced when osteoblastic
activity is increased.
The reported sensitivity of technetium-99 bone scanning is
between 80% and 100% (Table 78-1),4953 (Figures 78-3 and 78-4).
The bone scan can be normal in 5% to 20% of children with
osteomyelitis in the first few days of illness.52,5456 Bone scan is less
expensive than MRI, and sedation usually is not required. Bone
scan is particularly useful when multifocal bone involvement is
suspected.57
A variety of disorders, including malignancy, deep soft-tissue
infection, cellulitis, pyogenic arthritis, trauma, fracture, and bone
Osteomyelitis
Tuson etal.
Hamdan etal.50
Howie etal.51
Sullivan etal.52
Bressler etal.53
Year
Patient Age
1994
1987
1983
1980
1984
6 months13 years
6 months14 years
6 weeks13 years
3 weeks15 years
<6 weeks
Sensitivity (%)
92
89
89
81b
100
78
Figure 78-3. Typical technetium-99 bone scan findings of acute osteomyelitis in a 4-year-old girl who had a 2-day history of fever, ankle pain, and swelling, and
refusal to bear weight. Plain radiograph was unremarkable. Triple-phase anterior images of bone scan show increased tracer activity in the region of the right
ankle in the angiographic (immediate) phase (A), increased tracer activity in the soft tissues in the region of the ankle in the blood pool (15-minute) phase (B), and
localization of tracer in the distal tibial metaphysis (arrow) without periarticular distribution in the delayed (2.5-hour) phase (C). Diagnosis was confirmed at surgery
with finding of subperiosteal pus; Streptococcus pyogenes was isolated. (Courtesy of E. Geller and S.S. Long, St. Christophers Hospital for Children,
Philadelphia, PA.)
Figure 78-4. Plain film and technetium-99 bone scan of acute osteomyelitis and pyogenic arthritis in a 7-month-old boy who had a 3-day history of high fever,
fussiness and redness, and swelling of the lateral right leg from the thigh to the lower leg, with limitation of motion of the knee. Aspiration of the knee revealed
169,000 white blood cells/mm2 and gram-positive cocci. Plain film shows obscuration of right lateral subcutaneous fatmuscle plane, from the thigh to the lower
leg (A). Triple-phase bone scan shows increased tracer activity in the region of the right knee in the angiographic phase (B) and in the periarticular soft tissues
in the blood pool phase (C), as well as localization of tracer in the distal femur (arrow) but not in the proximal tibia in the delayed phase (D). Diagnosis of
osteomyelitis of the femur was confirmed at surgery. Methicillin-susceptible Staphylococcus aureus was isolated from blood, joint and bone specimens.
(Courtesy of E. Geller and S.S. Long, St. Christophers Hospital for Children, Philadelphia, PA.)
471
PART II Clinical Syndromes and Cardinal Features of Infectious Diseases: Approach to Diagnosis and Initial Management
SECTION K Bone and Joint Infections
Nuclear scanning using gallium-67 citrate or indium-111labeled leukocytes is positive in diseases characterized by increased
bone turnover and, thus, have limited specificity for osteomyelitis.59 Indium scanning, which reflects migration of white blood
cells into areas of inflammation, can be useful in the diagnosis of
osteomyelitis associated with trauma, surgery, chronic ulcers, or
prosthetic devices,60 but is limited by poor localization of infection (i.e., bone versus soft tissue), decreased sensitivity in diagnosing infection in the central skeleton, and relatively high radiation
exposure. Simultaneous performance of a technetium bone scan
sometimes increases specificity.61
TREATMENT
Antibiotic Choice
Considerations in choosing a specific antimicrobial regimen
include the age of the child, underlying medical conditions, suspected pathogens and their susceptibility pattern, antibiotic pharmacodynamics, and the safety and efficacy of the antibiotic.
Most -lactam antibiotics achieve therapeutic concentrations in
bone.67,68 Clindamycin has particularly good bone penetration,
attaining a high bone-to-serum ratio.67,6971 Vancomycin has excellent penetration into the bones of experimental animals.67
Aminoglycoside agents theoretically have poor bactericidal activity in bone because of local tissue hypoxia and acidosis. Although
ciprofloxacin penetrates well into bone, fluoroquinolones are not
recommended routinely for use in young children.72
Most cases of AHO in any age group are caused by S. aureus.
Empiric therapy should include coverage for this organism.
Parenterally administered nafcillin, clindamycin, or a firstgeneration cephalosporin historically have been the usual choices
for empiric therapy; however, the increase in CA-MRSA infections
has made the choice of initial antibiotic therapy challenging.
Direct sampling of bone for culture is increasingly important.
Clindamycin remains a good choice for empiric therapy in communities where resistance (both constitutive and inducible) occurs
in fewer than 10% of S. aureus isolates.41 In communities where
CA-MRSA resistance to clindamycin and methicillin is greater than
10% to 15%, vancomycin is the drug of choice for empiric
therapy.72a Clindamycin and vancomycin are active against most
isolates of S. pyogenes and S. pneumoniae. Neither offers coverage for
K. kingae infection, which is susceptible to most -lactam antibiotics. Ampicillin-sulbactam should be considered in addition to
clindamycin or vancomycin, especially in young children.
Empiric therapy for young children who have not been immunized against Haemophilus influenzae type b should include a
472
Duration of Therapy
Duration of antibiotic therapy depends on the cause and extent
of infection as well as the clinical course. The usual duration
ranges from 3 to 6 weeks and should be individualized on the
basis of severity of illness and clinical response. Historical evidence suggests that <3 weeks of treatment is associated with higher
rates of relapse or recurrence than longer duration of therapy.13
Plain radiographs obtained at the end of therapy may be useful
as a marker of maximal anticipated destruction, a baseline for
further studies, and a guide to possible complications.
Peripherally inserted or tunneled central venous catheter (PICC/
CVC) often is placed to continue intravenous antibiotics at home.
Use of PICC or CVC for >2 weeks in children with osteomyelitis
can be associated with an increase in catheter-related complications,87 including catheter malfunction, thrombosis and catheterassociated bloodstream infections.88
Osteomyelitis
78
Likely Pathogen
Antibiotic Selection
Doses/Day
>3 years
Staphylococcus aureus
Nafcillin
or
150
Clindamycinc
or
Vancomycin
<3 years
Neonate
S. aureus
Haemophilus influenzae type ba
Kingella kingaeb
S. aureus
Group B streptococcus
Enteric gram-negative bacteria
3040
34
4560
34
Nafcillin
or
Clindamycinc
or
Vancomycin
plus
Cefotaxime
or
Ceftriaxone
or
Cefuroxime
or
Ampicillin-sulbactam
150
300
Nafcillin
100
30
or
Vancomycin
plus
Gentamicin
OR
Nafcillin
or
Vancomycin
plus
Cefotaxime
3040
34
4560
34
100150
100
75150
57.5
100
30
150
If patient is fully immunized against Haemophilus influenzae type b, consider using only antistaphylococcal coverage.
If patient is treated with either clindamycin or vancomycin, consider adding an ampicillin or cephalosporin agent for Kingella kingae.
Doses/Day
Dicloxacillin
Cephalexin
Clindamycin
75100
100150
3040b
4
4
34
473
PART II Clinical Syndromes and Cardinal Features of Infectious Diseases: Approach to Diagnosis and Initial Management
SECTION K Bone and Joint Infections
Vertebral Osteomyelitis
Pelvic Osteomyelitis
TABLE 78-4. Frequency of Organisms Causing Neonatal
Osteomyelitis (n = 128)
474
Single Organism
Staphylococcus aureus
-Hemolytic streptococcus
Group B
Group A
Enteric gram-negative bacilli
Staphylococcus epidermidis
Nonhemolytic streptococcus
Streptococcus pneumoniae
Neisseria gonorrhoeae
Multiple organisms
60.6
16.5
3.1
8.7
2.4
2.4
0.8
0.8
4.7
Approximately 6% to 9% of all cases of hematogenous osteomyelitis involve the bones of the pelvis.40,137,138 The ilium and ischium
are most commonly involved;137 infection of the sacrum, acetabulum, or pubic symphysis is rare.137140 Risk factors (not always
present) include a history of pelvic trauma, intravenous drug use,
and genitourinary procedures.137,140
Most patients with pelvic osteomyelitis have fever, gait abnormalities, and pain that is often localized to the hip, groin, or
buttock.137,140143 Pain with hip movement and point tenderness
over the affected bone often is observed. Clinical features can
mimic those of pyogenic arthritis of the hip;137 however, in pelvic
osteomyelitis there is more likely to be near-normal range of
motion of the hip, absence of referred pain to the knee, specific
point tenderness over the affected bone (or pain on rocking of
the pelvic girdle), and abnormal rectal findings.143 Responsible
pathogens are similar to those that cause osteomyelitis of long
bones.
Osteomyelitis
78
Tuberculous Osteomyelitis
Skeletal lesions occur in approximately 1% of children with tuberculosis.130,164 Bones and joints are infected through hematogenous
or lymphatic dissemination of Mycobacterium tuberculosis. Infection can smolder for years before clinical signs are apparent. The
most commonly involved bones are the vertebrae (tuberculous
spondylitis), femur, long bones around knees and ankles, and
small bones of the hands and feet.165 Other sites less frequently
infected are the ribs, mandible, sternum, clavicle, and other long
bones. Multifocal osteomyelitis is reported in 10% to 15% of
cases.166,167
Clinical signs and symptoms of skeletal tuberculosis include
low-grade fever, weight loss, pain, and soft-tissue swelling at the
site of infection. Vertebral involvement begins in the anterior
vertebral body, eventually causing disk space collapse and anterior
wedging of vertebral bodies, and sometimes gibbus deformity. The
lower thoracic spine is the usual site of involvement (Pott disease),
followed by the lumbar spine.
The Mantoux tuberculin skin reaction is usually positive. The
role of interferon- release assays in the diagnosis of Pott disease
is currently being evaluated. Plain radiographic findings include
periarticular osteopenia, lytic lesions in the body of the vertebra,
joint space narrowing, and soft-tissue swelling.168 The chest radiograph often is normal. CT is useful for the evaluation of bone
destruction, adjacent soft-tissue abscess formation, and calcification, and in guiding percutaneous biopsy.169,170 MRI is helpful in
determining extent of bone and soft-tissue disease.171 Biopsy specimens should be obtained in an attempt to demonstrate the organism with stains and culture.
Antituberculous therapy includes 2 months of therapy with four
drugs, followed by 7 to 10 months of isoniazid and rifampin
(for susceptible organisms) daily or twice weekly (see Chapter
134, Mycobacterium tuberculosis).172 Surgical intervention is
indicated in cases of spinal instability and neurologic impairment
secondary to paravertebral abscess formation and for drainage
of soft-tissue abscesses. Nontuberculous Mycobacterium spp.
infrequently cause osteomyelitis in immunocompromised
individuals.
475
PART II Clinical Syndromes and Cardinal Features of Infectious Diseases: Approach to Diagnosis and Initial Management
SECTION K Bone and Joint Infections
NONHEMATOGENOUS OSTEOMYELITIS
Contiguous Infection
Factors associated with the development of nonhematogenous
osteomyelitis include open fractures requiring surgical reduction,176,177 implanted orthopedic devices, decubitus ulcers,173 and
neuropathic ulcers.178,179 Facial osteomyelitis usually is secondary
to untreated mastoiditis, sinusitis, or periodontal abscess.173,177
Osteomyelitis can occur after local soft-tissue infection or direct
inoculation of bone from human and animal bites.180,181 Puncture
wounds can lead to osteomyelitis of the foot (e.g., stepping on a
nail or toothpick182) or the patella (e.g., kneeling on a needle).
Indolent presentation is common among children with non
hematogenous osteomyelitis. Fever is present in less than half of
patients.183 Persistent drainage or ulceration of the soft tissue over
the affected bone is typical. Plain radiograph shows bony destruction. Peripheral white blood cell count often is normal, and ESR
and CRP can be normal.
Nonhematogenous osteomyelitis often is caused by S. aureus,
although coinfection with gram-negative and anaerobic organisms occurs.174 Examination of specimens from an associated sinus
tract is unreliable in defining the etiology of osteomyelitis.184
Biopsy with culture of the affected bone is the best method of
determining appropriate antibiotic therapy. Therapy should be
prolonged if infection is chronic, sometimes with parenteral
therapy followed by oral therapy for a total of 4 to 6 months.
The rate of recurrence in nonhematogenous osteomyelitis is as
high as 40%, even with prolonged courses of antibiotic therapy.183
Aggressive surgical debridement or other interventions are required
in addition to antibiotic therapy. Implanted devices commonly
must be removed for cure. Debridement followed by muscle flap
procedure to re-establish the blood supply in decubitus ulcerassociated osteomyelitis frequently is beneficial.185
476
CHRONIC OSTEOMYELITIS
Chronic osteomyelitis develops in fewer than 5% of cases
of AHO;12,206 it more often follows nonhematogenous
osteomyelitis.183
Osteomyelitis
REFERENCES
1. Winters JL, Cahen I. Acute hematogenous osteomyelitis:
a review of sixty-six cases. J Bone Joint Surg Am 1960;42:97.
2. Trueta J. The three types of acute haematogenous
osteomyelitis: a clinical and vascular study. J Bone Joint Surg
Br 1959;41:671.
3. Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review
of clinical features, therapeutic considerations and unusual
aspects (first of three parts). N Engl J Med 1970;282:198.
4. Anderson CE, Parker J. Invasion and resorption in enchondral
ossification: an electron microscope study. J Bone Joint Surg
Am 1966;48:899.
5. Howlett CR. The fine structure of the proximal growth plate
and metaphysis of the avian tibia: endochondral osteogenesis.
J Anat 1980;130:745.
6. Emslie KR, Nade S. Pathogenesis and treatment of acute
hematogenous osteomyelitis: evaluation of current views with
reference to an animal model. Rev Infect Dis 1986;8:841.
7. Mayberry-Carson KJ, Tober-Meyer B, Smith JK, et al. Bacterial
adherence and glycocalyx formation in osteomyelitis
experimentally induced with Staphylococcus aureus. Infect
Immun 1984;43:825.
8. Trueta J. The normal vascular anatomy of the human femoral
head during growth. J Bone Joint Surg Br 1957;39:358.
9. Ogden JA, Lister G. The pathology of neonatal osteomyelitis.
Pediatrics 1975;55:474.
10. Gillespie WJ. The epidemiology of acute haematogenous
osteomyelitis of childhood. Int J Epidemiol 1985;14:600.
11. Hevroni A, Koplewitz BZ. Images in medicine. Bone within
bone: chronic osteomyelitis. N Engl J Med 2007;35:e7.
12. Nelson JD. Acute osteomyelitis in children. Infect Dis Clin
North Am 1990;4:513.
13. Dich VQ, Nelson JD, Haltalin KC. Osteomyelitis in infants
and children. Am J Dis Child 1975;129:1273.
14. Rossaak M, Pitto RP. Osteomyelitis in Polynesian children.
Int Orthop 2005;29:55.
15. Lebel MH, Nelson JD. Haemophilus influenzae type b
osteomyelitis in infants and children. Pediatr Infect Dis J
1988;7:250.
16. Waldvogel FA, Papageorgiou PS. Osteomyelitis: the past
decade. N Engl J Med 1980;303:360.
17. Scott RJ, Christoferson MR, Robertson WW, et al. Acute
osteomyelitis in children: a review of 116 cases. J Pediatr
Orthop 1990;10:649.
18. Faden H, Grossi M. Acute osteomyelitis in children:
reassessment of etiologic agents and their clinical
characteristics. Am J Dis Child 1991;145:65.
19. Blyth MJG, Kincaid R, Craigen MAC, et al. The changing
epidemiology of acute and subacute haematogenous
osteomyelitis in children. J Bone Joint Surg Br
2001;83:99102.
20. Kiang KM, Ogunmodede F, Juni BA, et al. Outbreak of
osteomyelitis/septic arthritis caused by Kingella kingae among
child care center attendees. Pediatrics 2005;116:e206.
21. Moumile K, Merckx J, Glorion JC, et al. Bacterial aetiology of
acute osteoarticular infections in children. Acta Paediatr
2005;94:419.
22. Bradley JS, Kaplan SL, Tan TQ, et al. Pediatric pneumococcal
bone and joint infections. Pediatrics 1998;102:1376.
23. Ibia Eo, Imoisili M, Pikis A. Group A beta-hemolytic
streptococcal osteomyelitis in children. Pediatrics
2003;112:e22.
24. Black S, Shinefield H, Baxter R, et al. Postlicensure
surveillance for pneumococcal invasive disease after use of
heptavalent pneumococcal conjugate vaccine in Northern
California Kaiser Permanente. Pediatr Infect Dis J
2004;23:485.
78
477.e1
PART II Clinical Syndromes and Cardinal Features of Infectious Diseases: Approach to Diagnosis and Initial Management
SECTION K Bone and Joint Infections
45. Unkila-Kallio L, Kallio MJ, Eskola J, et al. Serum C-reactive
protein, erythrocyte sedimentation rate, and white blood cell
count in acute hematogenous osteomyelitis of children.
Pediatrics 1994;93:59.
46. Roine I, Arguedas A, Faingezicht I, et al. Early detection
of sequela-prone osteomyelitis in children with use of
simple clinical and laboratory criteria. Clin Infect Dis
1997;24:849.
47. Hollmig ST, Copley LA, Browne RH, et al. Deep venous
thrombosis associated with osteomyelitis in children. J Bone
Joint Surg Am 2007;89(7):1517.
48. Capitanio MA, Kirkpatrick JA. Acute roentgen observations in
acute osteomyelitis. AJR 1970;108:488.
49. Tuson CE, Hoffman EB, Mann MD. Isotope bone scanning
for acute osteomyelitis and septic arthritis in children. J Bone
Joint Surg Br 1994;76:306310.
50. Hamdan J, Mohassed A, Mallouh A, et al. Technetium bone
scintigraphy in the diagnosis of osteomyelitis in children.
Pediatr Infect Dis J 1987;6:529.
51. Howie DW, Savage JP, Wilson TG, et al. The technetium
phosphate bone scan in the diagnosis of osteomyelitis in
childhood. J Bone Joint Surg Am 1983;65:431.
52. Sullivan DC, Rosenfield NS, Ogden S, et al. Problems in the
scintigraphic detection of osteomyelitis in children. Radiology
1980;135:731.
53. Bressler EL, Conway JJ, Weiss SC. Neonatal osteomyelitis
examined by bone scintigraphy. Radiology 1984;152:685.
54. Wald ER, Mirro R, Gartner JC. Pitfalls on the diagnosis of
acute osteomyelitis by bone scan. Clin Pediatr 1980;19:597.
55. Berkowitz ID, Wenzel W. Normal technetium bone scans in
patients with acute osteomyelitis. Am J Dis Child
1980;134:828.
56. Fleisher GR, Paradise JE, Plotkin SA, et al. Falsely normal
radionuclide scans for osteomyelitis. Am J Dis Child
1980;134:499.
57. Connolly LP, Connolly SA, Drubach LA, et al. Acute
hematogenous osteomyelitis of children: assessment of
skeletal scintigraphy-based diagnosis in the era of MRI. J Nucl
Med 2002;43:1310.
58. Pennington WT, Mott MP, Thometz JG, et al. Photopenic
bone scan osteomyelitis: a clinical perspective. J Pediatr
Orthop 1999;19:695.
59. Tsan M. Mechanism of gallium-67 accumulation in
inflammatory lesions. J Nucl Med 1985;26:88.
60. Schauwecker DS, Park HM, Mock BH, et al. Evaluation of
complicating osteomyelitis with Tc-99m MDP, In-111
granulocytes, and Ga-67 citrate. J Nucl Med 1984;25:849.
61. Schauwecker DS. Osteomyelitis: diagnosis with In-111 labeled
leukocytes. Radiology 1989;171:141.
62. Mazur JM, Ross G, Cummings RJ, et al. Usefulness of
magnetic resonance imaging for the diagnosis of acute
musculoskeletal infections in children. J Pediatr Orthop
1995;15:144.
63. Dangman BC, Hoffer JA, Rand FF, et al. Osteomyelitis in
children: gadolinium-enhanced MR imaging. Radiology
1992;182:743.
64. Fletcher BD, Scoles PV, Nelson AD. Osteomyelitis in children:
detection by magnetic resonance. Radiology 1984;150:57.
65. Cohen D, Cory DA, Kleiman M, et al. Magnetic resonance
differentiation of acute and chronic osteomyelitis in children.
Clin Radiol 1990;41:53.
66. Averill LW, Hernandez A, Gonzalez L, et al. Diagnosis of
osteomyelitis in children: utility of fat-suppressed contrastenhanced MRI. AJR Am J Roentgenol 2009;192:1232.
67. Mader JT, Landon GC, Calhoun J. Antimicrobial treatment of
osteomyelitis. Clin Orthop 1993;295:87.
68. Tetzlaff TR, Howard JB, McCracken GH, et al. Antibiotic
concentrations in pus and bone of children with
osteomyelitis. J Pediatr 1978;92:135.
477.e2
Osteomyelitis
89. Tetzlaff TR, McCracken GH Jr, Nelson JD. Oral antibiotic
therapy for skeletal infections of children. II: Therapy of
osteomyelitis and suppurative arthritis. J Pediatr 1978;92:485.
90. Bryson YJ, Connor JD, LeClerc M, et al. High-dose oral
dicloxacillin treatment of acute staphylococcal osteomyelitis
in children. J Pediatr 1979;94:673.
91. Kolyvas E, Ahronheim G, Marks MI, et al. Oral antibiotic
therapy of skeletal infections in children. Pediatrics
1980;65:867.
92. Syrogiannopoulos GA, Nelson JD. Duration of antimicrobial
therapy for acute suppurative osteoarticular infections. Lancet
1988;1:37.
93. Peltola H, Unkila-Kallio L, Kallio MJT. Simplified treatment
of acute staphylococcal osteomyelitis of childhood. Pediatrics
1997;99:846.
94. Karwowska A, Davies D, Jadavji T. Epidemiology and
outcome of osteomyelitis in the era of sequential intravenousoral therapy. Pediatr Infect Dis J 1998;17:1021.
95. Asmar BI. Osteomyelitis in the neonate. Infect Dis Clin North
Am 1992;6:117.
96. Fox L, Sprunt K. Neonatal osteomyelitis. Pediatrics
1978;62:535.
97. Frederiksen B, Christiansen P, Knudsen FU. Acute
osteomyelitis and septic arthritis in the neonate: risk factors
and outcome. Eur J Pediatr 1993;152:577.
98. Lim MO, Gersham EL, Franken EA, et al. Osteomyelitis as a
complication of umbilical artery catheterization. Am J Dis
Child 1977;131:142.
99. Simmons PB, Harris LE, Bianco AJ. Complications of
exchange transfusion: Report of two cases of septic arthritis
and osteomyelitis. Mayo Clin Proc 1973;48:190.
100. Brook I. Osteomyelitis and bacteremia caused by Bacteroides
fragilis: a complication of fetal monitoring. Clin Pediatr
1980;19:639.
101. Overturf GD, Balfour G. Osteomyelitis and sepsis: severe
complications of fetal monitoring. Pediatrics 1975;55:244.
102. McGregor JA, McFarren T. Osteomyelitis: a complication of
fetal monitoring. Obstet Gynecol 1989;73:490.
103. Mohon RT, Mehalic TF, Grimes CK, et al. Infected
cephalhematoma and neonatal osteomyelitis of the skull.
Pediatr Infect Dis J 1986;5:253.
104. Brook I. Infected neonatal cephalohematomas caused by
anaerobic bacteria. J Perinat Med 2005;33:255.
105. Lilien LD, Harris VJ, Ramamurthy RS, et al. Neonatal
osteomyelitis of the calcaneus: complication of heel puncture.
J Pediatr 1976;88:478.
106. Wong M, Isaacs D, Howman-Giles R, et al. Clinical and
diagnostic features of osteomyelitis occurring in the first three
months of life. Pediatr Infect Dis J 1995;14:1047.
107. Weissberg ED, Smith AL, Smith DH. Clinical features of
neonatal osteomyelitis. Pediatrics 1974;53:505.
108. Williamson JB, Galasko CS, Robinson MJ. Outcome after
acute osteomyelitis in preterm infants. Arch Dis Child
1990;65:1060.
109. Bergdahl S, Ekengren K, Eriksson M. Neonatal hematogenous
osteomyelitis: risk factors for long-term sequelae. J Pediatr
Orthop 1985;5:564.
110. Healy CM, Hulten KG, Palazzi DL, et al. Emergence of new
strains of methicillin-resistant Staphylococcus aureus in a
neonatal intensive care unit. Clin Infect Dis 2004;39:1460.
111. Oleinik EM, Della-Latta P, Rinaldi MG, et al. Candida
lusitaniae osteomyelitis in a premature infant. Am J Perinatol
1993;10:313.
112. Gjuric G, Prislin-Muskic M, Nikolic E, et al. Ureaplasma
urealyticum osteomyelitis in a very low birth weight infant.
J Perinat Med 1994;22:79.
113. Edwards MS, Baker CJ, Wagner ML, et al. An etiologic shift in
infantile osteomyelitis: the emergence of the group B
Streptococcus. J Pediatr 1978;93:578.
78
477.e3
PART II Clinical Syndromes and Cardinal Features of Infectious Diseases: Approach to Diagnosis and Initial Management
SECTION K Bone and Joint Infections
139. Ukwu HN, Graham BS, Latham RH. Acute pubic
osteomyelitis in athletes. Clin Infect Dis 1992;15:636.
140. Busto RD, Quinn EL, Fisher EJ, et al. Osteomyelitis of the
pubis. JAMA 1982;248:1498.
141. Farley T, Conway J, Shulman ST. Hematogenous pelvic
osteomyelitis in children. Am J Dis Child 1985;139:946.
142. Highland TR, LaMont RL. Osteomyelitis of the pelvis in
children. J Bone Joint Surg Am 1983;65:230.
143. Edwards MS, Baker CJ, Granberry WM, et al. Pelvic
osteomyelitis in children. Pediatrics 1978;61:62.
144. Connolly SA, Connolly LP, Drubach LA, et al. MRI for
detection of abscess in acute osteomyelitis of the pelvis in
children. AJR Am J Roentgenol 2007;189:867.
145. Piehl FC, Davis RJ, Prugh SI. Osteomyelitis in sickle cell
disease. J Pediatr Orthop 1993;13:225.
146. Epps CH, Bryant DD, Coles MJ, et al. Osteomyelitis in
patients who have sickle-cell disease. J Bone Joint Surg Am
1991;73:1281.
147. Johnston RB. Increased susceptibility to infection in sickle cell
disease: review of its occurrence and possible causes. South
Med J 1974;67:1324.
148. Syrogiannopoulos GA, McCracken GH, Nelson JD.
Osteoarticular infections in children with sickle cell disease.
Pediatrics 1986;78:1090.
149. Givner LB, Luddy RE, Schwartz AD. Etiology of osteomyelitis
in patients with major sickle hemoglobinopathies. J Pediatr
1981;99:411.
150. Mallouh A, Talab Y. Bone and joint infection in patients with
sickle cell disease. J Pediatr Orthop 1985;5:158.
151. Burnett MW, Bass JW, Cook BA. Etiology of osteomyelitis
complicating sickle cell disease. Pediatrics 1998;101:296.
152. Reynolds J. Radiologic manifestations of sickle cell
hemoglobinopathy. JAMA 1977;238:247.
153. Bonnerot V, Sebag G, de Montalembert M, et al. GadoliniumDOTA enhanced MRI of painful osseous crises in children
with sickle cell anemia. Pediatr Radiol 1994;24:92.
154. Glick C, Graves GR, Feldman S. Neonatal fungemia and
amphotericin B. South Med J 1993;86:1368.
155. Ward RM, Sattler FR, Dalton SA. Assessment of antifungal
therapy in an 800-gram infant with candidal arthritis and
osteomyelitis. Pediatrics 1983;72:234.
156. Dato VM, Dajani AS. Candidemia in children with central
venous catheters: role of catheter removal and amphotericin
B therapy. Pediatr Infect Dis J 1990;9:309.
157. Collignon PJ, Sorrell TC. Disseminated candidiasis: evidence
of a distinctive syndrome in heroin abusers. Br Med J
1983;287:861.
158. Hendrickx L, Wijngaerden EV, Samson I, et al. Candidal
vertebral osteomyelitis: report of 6 patients, and a review.
Clin Infect Dis 2001;32:527-533.
159. Sponseller PD, Malech HL, McCarthy EF, et al. Skeletal
involvement in children who have chronic granulomatous
disease. J Bone Joint Surg Am 1991;73:37.
160. Leggiadro RJ, Barrett FF, Hughes WT. Disseminated
histoplasmosis of infancy. Pediatr Infect Dis J 1988;7:799.
161. Rhangos WC, Chick EW. Mycotic infections of bone. South
Med J 1964;57:664.
162. MacDonald PB, Black GB, MacKenzie R. Orthopaedic
manifestations of blastomycosis. J Bone Joint Surg Am
1990;72:860.
163. Zerbe CS, Holland SM. Disseminated histoplasmosis in
persons with interferon-gamma receptor 1 deficiency. Clin
Infect Dis 2005;41:e38.
164. Snider D, Rieder H, Combs D, et al. Tuberculosis in children.
Pediatr Infect Dis J 1988;7:271.
165. Waldvogel F, Medoff G, Swartz MN. Osteomyelitis: a review
of clinical features, therapeutic considerations and unusual
aspects (third of three parts). N Engl J Med 1970;282:316.
477.e4
Osteomyelitis
190. Fisher MC, Goldsmith JF, Gilligan PH. Sneakers as a source of
Pseudomonas aeruginosa in children with osteomyelitis
following puncture wounds. J Pediatr 1985;106:607.
191. Jacobs RF, Adelman L, Sack CM, et al. Management of
Pseudomonas osteochondritis complicating puncture wounds
of the foot. Pediatrics 1982;69:432.
192. Raz R, Miron D. Oral ciprofloxacin for treatment of infection
following nail puncture wounds of the foot. Clin Infect Dis
1995;21:194.
193. Schultz C, Holterhus PM, Seidel A, et al. Chronic recurrent
multifocal osteomyelitis in children. Pediatr Infect Dis J
1999;18:1008.
194. Chun CS. Chronic recurrent multifocal osteomyelitis of the
spine and mandible: case report and review of the literature.
Pediatrics 2004;113:380.
195. King SM, Laxer RM, Manson D, et al. Chronic recurrent
multifocal osteomyelitis: a noninfectious inflammatory
process. Pediatr Infect Dis J 1987;6:907.
196. Bjorksten B, Gustavson KH, Eriksson B, et al. Chronic
recurrent multifocal osteomyelitis and pustulosis
palmoplantaris. J Pediatr 1978;93:227.
197. Huber AM, Lam P-Y, Duffy CM, et al. Chronic
recurrent multifocal osteomyelitis: clinical outcome
after more than five years of follow-up. J Pediatr
2002;141:198.
198. Probst F, Bjorksten B, Gustavson K-H. Radiological aspect of
chronic recurrent multifocal osteomyelitis. Ann Radiol
1978;21:115.
199. Mortensson W, Edeburn G, Fries M, et al. Chronic
recurrent multifocal osteomyelitis in children: a
roentgenologic and scintigraphic investigation. Acta Radiol
1988;29:565.
200. Machiels F, Seynaeve P, Lagey C, et al. Chronic recurrent
multifocal osteomyelitis with MR correlation: a case report.
Pediatr Radiol 1992;22:535.
78
201. Dawson JS, Webb JK, Preston BJ. Case report: chronic
recurrent multifocal osteomyelitis with magnetic resonance
imaging. Clin Radiol 1994;49:133.
202. Solheim LF, Paus B, Liverud K, et al. Chronic recurrent
multifocal osteomyelitis. Acta Orthop Scand 1980;51:37.
203. Catalano-Pons C, Comte A, Wipff J, et al. Clinical outcome in
children with chronic recurrent multifocal osteomyelitis.
Rheumatology (Oxford) 2008;47(9):1397.
204. Gallagher KT, Roberts RL, MacFarlane JA, et al. Treatment of
chronic recurrent multifocal osteomyelitis with interferon
gamma. J Pediatr 1997;131:470.
205. Bjorksten B, Boquist L. Histopathological aspects of chronic
recurrent multifocal osteomyelitis. J Bone Joint Surg Br
1980;62:376.
206. Gillespie WJ, Mayo KM. The management of acute
haematogenous osteomyelitis in the antibiotic era: a study of
the outcome. J Bone Joint Surg Br 1981;63:126.
207. Mader JT, Shirtliff ME, Bergquist SC, et al. Antimicrobial
treatment of chronic osteomyelitis. Clin Orthop
1999;360:4765.
208. Henry SL, Hood GA, Seligson D. Long term implantation of
gentamicin polymethyl-methacrylate antibiotic beads. Clin
Orthop 1993;295:47.
209. Perry CR, Pearson RL. Local antibiotic delivery in the
treatment of bone and joint infections. Clin Orthop
1991;263:215.
210. Fitzgerald RH, Ruttle PE, Arnold PG, et al. Local muscle flaps
in the treatment of chronic osteomyelitis. J Bone Joint Surg
Am 1985;67:175.
211. Patzakis MJ, Abdollahi K, Sherman R, et al. Treatment of
chronic osteomyelitis with muscle flaps. Orthop Clin North
Am 1993;24:505.
212. Anthony JP, Mathes SJ, Alpert BS. The muscle flap in the
treatment of lower extremity osteomyelitis: results in patients
over 5 years of treatment. Plast Reconstr Surg 1991;88:311.
477.e5